Pharmacy
GLP1 Receptor Agonist Use Does Not Seem to Increase Risk for Thyroid Cancer
No increased risk for thyroid cancer seen with use of GLP1 receptor agonist versus DPP4 inhibitor use, SGLT2 inhibitor use
AI May Be Useful in Polypharmacy Management
ChatGPT deprescribing decisions varied along activities of daily living status, cardiovascular disease history, and medication type
New Rules Mean 3.6 Million Americans Could Get Wegovy Via Medicare, Costing Billions
Antihypertensive Meds Initiation Linked to Fractures in Nursing Home Seniors
Antihypertensive medication initiation also linked to higher risk for severe falls requiring hospitalization, ED visits
Alecensa Approved as First and Only ALK Inhibitor for Non-Small Cell Lung Cancer
Drug approved for patients with ALK-positive, early-stage cancer who undergo surgery to remove their tumor
Aspirin May Enhance Immunosurveillance Against Colorectal Cancer
Aspirin users have nodal metastases significantly less often, higher infiltration of tumor-infiltrating lymphocytes
ACP: Recommendations Developed for Newer Type 2 Diabetes Medications
Strong recommendation given for addition of SGLT-2 or GLP-1 agonist to metformin and lifestyle modifications
ACP: Next-Generation Antibiotics Underused for Gram-Negative Infections
41.5 percent of difficult-to-treat resistance episodes were treated exclusively with traditional agents
Risk for Adverse Outcomes Increased With Antipsychotic Use in Dementia
Risks increased for stroke, venous thromboembolism, myocardial infarction, heart failure, fracture, pneumonia, acute kidney injury
Computer Prompts Could Reduce Empiric Antibiotic Use for UTI
17.4 percent reduction seen in empiric extended-spectrum days of therapy, with no increase in safety outcomes